The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects
NCT ID: NCT02581020
Last Updated: 2021-12-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
344 participants
OBSERVATIONAL
2016-01-14
2020-12-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Participants who were treated with 2D regimen (ombitasvir/ paritaprevir/ ritonavir) and completed 48 weeks of follow up from the prior Phase 2 or 3 studies conducted in Japan.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants who agree to sign the informed consent
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AbbVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AbbVie Inc.
Role: STUDY_DIRECTOR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nagoya City University Hospital /ID# 157439
Nagoya, Aichi-ken, Japan
Matsuyama Red Cross Hospital /ID# 152125
Matsuyama, Ehime, Japan
National Hospital Organization Kyushu Medical Center /ID# 161759
Fukuoka, Fukuoka, Japan
Fukuoka University Hospital /ID# 155965
Fukuoka, Fukuoka, Japan
Kurume University Hospital /ID# 152123
Kurume-shi, Fukuoka, Japan
Ogaki Municipal Hospital /ID# 158105
Ogaki-shi, Gifu, Japan
Gunma University Hospital /ID# 158118
Maebashi, Gunma, Japan
National Hospital Organization Takasaki General Medical Center /ID# 152128
Takasaki-shi, Gunma, Japan
Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital /ID# 152178
Hiroshima, Hiroshima, Japan
Hiroshima University Hospital /ID# 152232
Hiroshima, Hiroshima, Japan
Obihiro kosei Hospital /ID# 157437
Obihiro-shi, Hokkaido, Japan
Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital /ID# 153019
Sapporo, Hokkaido, Japan
Hitachi General Hospital /ID# 160800
Hitachi-shi, Ibaraki, Japan
Duplicate_Kanazawa University Hospital /ID# 152226
Kanazawa, Ishikawa-ken, Japan
Kagawa University Hospital /ID# 153548
Kita-gun, Kagawa-ken, Japan
Duplicate_Yokohama City University Medical Center /ID# 159474
Yokohama, Kanagawa, Japan
Yokohama City University Hospital /ID# 165252
Yokohama, Kanagawa, Japan
Kumamoto Shinto General Hospital /ID# 150061
Kumamoto, Kumamoto, Japan
Okayama University Hospital /ID# 150060
Okayama, Okayama-ken, Japan
Osaka City General Hospital /ID# 152126
Osaka, Osaka, Japan
Japanese Red Cross Osaka Hospital /ID# 155964
Osaka, Osaka, Japan
Saga University Hospital /ID# 161757
Saga, Saga-ken, Japan
Saitama Medical University Hospital /ID# 153544
Iruma-gun, Saitama, Japan
Hamamatsu University Hospital /ID# 152176
Hamamatsu, Shizuoka, Japan
Dokkyo Medical University Hospital /ID# 152225
Shimotsuga-gun, Tochigi, Japan
Jichi Medical University Hospital /ID# 153018
Shimotsuke-shi, Tochigi, Japan
Juntendo University Hospital /ID# 153545
Bunkyo-ku, Tokyo, Japan
The University of Tokyo Hospital /ID# 158121
Bunkyo-ku, Tokyo, Japan
Toranomon Hospital /ID# 152124
Minato-ku, Tokyo, Japan
Kitasato University Kitasato Institute Hospital /ID# 152145
Minato-ku, Tokyo, Japan
Toyama Prefectural Central Hospital /ID# 164156
Toyama, Toyama, Japan
Yamaguchi University Hospital /ID# 166899
Ube-shi, Yamaguchi, Japan
University of Yamanashi Hospital /ID# 153547
Chuo-shi, Yamanashi, Japan
Asakura Medical Association Ho /ID# 155963
Asakura, , Japan
Fukuiken Saiseikai Hospital /ID# 162898
Fukui, , Japan
Gifu Municipal Hospital /ID# 152227
Gifu, , Japan
Gifu Prefectural Genl Med Ctr /ID# 154796
Gifu, , Japan
Ikeda Municipal Hospital /ID# 150062
Ikeda, , Japan
Tokyo Med Uni Ibaraki Med Ctr /ID# 152127
Inashiki, , Japan
Nippon Med Chiba Hokusoh Hosp /ID# 164155
Inzai, , Japan
Kagoshima Uni Med and Dental /ID# 157438
Kagoshima, , Japan
Toranomon Hospital Kajigaya /ID# 152129
Kawasaki, , Japan
Kawasaki Municipal Tama Hospit /ID# 153546
Kawasaki, , Japan
Ehime Prefectural Central Hosp /ID# 158106
Matsuyama, , Japan
Kawasaki Hosp, Kawasaki Med /ID# 152180
Okayama, , Japan
Osaka Hospital /ID# 152177
Osaka, , Japan
Japanese Red Cross Saitama Hos /ID# 166898
Saitama, , Japan
Saiseikai Suita Hospital /ID# 153549
Suita, , Japan
Kagawa Prefectural Central Hos /ID# 152179
Takamatsu, , Japan
Nat Hosp Org Minami Wakayama /ID# 153550
Tanabe, , Japan
Toshiba General Hospital /ID# 152122
Tokyo, , Japan
JP Red Cross Musashino Hosp /ID# 152175
Tokyo, , Japan
Oita University Hospital /ID# 165274
Yufu-shi, , Japan
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
clinical study report synopsis
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P15-349
Identifier Type: -
Identifier Source: org_study_id